908 Devices Stock
908 Devices Inc.
Company data
- Sector
- Healthcare
- Industry
- Medical - Specialties
- Country
- United States
- CEO
- Kevin J. Knopp
- Employees
- 172
- Market cap
- $465 M
- IPO
- 18/12/2020
908 Devices Inc. provides purpose-built handheld mass spectrometry and fourier transform infrared (FTIR) devices for use in vital health and safety applications. The company’s products include MX908, a handheld, battery-powered, and Mass Spec device that is designed for rapid analysis of solid, liquid, vapor, and…
908 Devices stock: price history
1D
-5.3%
1W
-6.6%
1M
+13.5%
6M
+57.3%
YTD
+114.5%
1Y
+29.7%
2Y
+219.0%
5Y
-64.9%
10Y
–
Next earnings date
Next earnings date
09/11/2026 (in 23 days)
Volatility around earnings
~93% stronger price swings than usual
908 Devices stock scores
- Valuation
Visible after free registration
- Trend
Visible after free registration
- Quality
Visible after free registration
- Dividend
Visible after free registration
- Growth
Visible after free registration
- Insider
Visible after free registration
- Earnings
Visible after free registration
- Revisions
Visible after free registration
- Sentiment
Visible after free registration
- Short Pressure
Visible after free registration
Register for free
Unlock all 11 scores
- 5 credits free on registration
- Access to virtual portfolios and watchlist
- No credit card, no payment details needed
- No subscription, no minimum term
- Our own servers in Germany, no US cloud
Deterministically calculated from financial metrics, not investment advice. Updated nightly, last on 17/10/2026.
Business model & megatrends
Very robust business model with strong megatrend tailwind: wide moat, strong pricing power, predictable revenue.
1 more assignment (Enabler/Second row) Pro-only.
908 Devices Inc. develops and distributes specialized handheld analytical instruments for mass spectrometry and Fourier-transform infrared spectroscopy. These devices are used in critical areas of health, safety, and environmental protection to rapidly identify unknown substances such as gases, liquids, or powders. The business model combines hardware sales with recurring revenue from service offerings and maintenance contracts. Through the use of proprietary signal processing algorithms, the company provides highly specialized technology solutions. Operations are conducted globally, with a focus on the US market.
- Revenue model
- Mixed
- Recurring revenue
- Medium
- Pricing power
- Strong
- Moat
- Narrow
- Moat type
- Regulatory
- Capital intensity
- Low
- Customer concentration
- Unknown
Ask the agents about 908 Devices
Analyst assessment of 908 Devices
PRICE TARGET LOW
US$12.00
CONSENSUS
US$12.00
MEDIAN
US$12.00
PRICE TARGET HIGH
US$12.00
0
STRONG BUY
6
BUY
0
HOLD
0
SELL
0
STRONG SELL
6
TOTAL · Buy
As of: 12/08/2026
908 Devices stock metrics
P/E
-12.11
P/B
3.35
EV/EBITDA
-13.66
RETURN ON EQUITY
-9.4%
NET MARGIN
-74.0%
DEBT/EQUITY
0.03
DIVIDEND YIELD
0.0%
AS OF
30/06/2026
Free float & liquidity
FREE FLOAT
79.1%
FLOAT SHARES
32,692,105
AVG. DAILY VOLUME (30D)
372,758
Insider transactions (SEC)
Brown Christopher D.
Brown Christopher D.
Griffith Joseph H. IV
AWM Investment Company, Inc.
AWM Investment Company, Inc.
Attention
Price since yesterday: -5.3%
Search (Google Trends)
Institutional holders
Comparable stocks
Frequently asked questions about 908 Devices stock
What does 908 Devices do?
908 Devices Inc. is a company in the Healthcare sector, Medical - Specialties industry, headquartered in United States.
The CEO is Kevin J. Knopp, the company employs around 172 people.
The IPO was on 18/12/2020; the stock trades on NASDAQ under the ticker MASS.
What do analysts say about 908 Devices stock?
6 analysts rate the stock, the consensus is Buy (as of 12/08/2026).
The average price target is US$12.00, ranging from US$12.00 to US$12.00, with a median of US$12.00.
This is an external assessment, not a statement by Market Jury.
When does 908 Devices report next?
The next earnings date is 09/11/2026.
Around past earnings, price swings were roughly 93% stronger than usual.
Does 908 Devices pay a dividend?
No, 908 Devices currently does not pay a dividend.
Which stocks are comparable to 908 Devices?
Comparable stocks include STERIS, QuidelOrtho, Mesa Laboratories, Trinity Biotech, Eli Lilly and Company, Johnson & Johnson, AbbVie and Merck &.
How can I get 908 Devices stock analyzed?
Clicking "Analyze stock" lets five strategies assess 908 Devices against fixed, published rules and judge it bullish, neutral or bearish. The jury states where it disagrees. A free account starts with 5 credits, a quick check costs 1 credit, a full analysis 2 credits.
Not investment advice. Past performance is not an indicator of future results.